| 2024-12-04 |
[Correspondence] Predictors of pregnancy outcomes in SLE |
Wenqin He, Xiaoyu Tang, Rongjing Shi, Dan Ma, Li-Yun Zhang |
|
| 2024-12-04 |
[Correspondence] Predictors of pregnancy outcomes in SLE |
Maria I Zervou, George N Goulielmos |
|
| 2024-12-04 |
[Correspondence] Predictors of pregnancy outcomes in SLE – Authors' reply |
Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper, Marieke Sueters, Y K Onno Teng, Isabel J Walter, Judith Kooiman |
|
| 2024-11-23 |
[Comment] Targeting sphingosine-1-phosphate receptor modulator in SLE: a promising new therapeutic option |
Giuseppe Barilaro, Ricard Cervera |
|
| 2024-11-23 |
[Articles] Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial |
Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra, Clélia Cahuzac, Peter Cornelisse, Mark J Murphy, Daniel S Strasser, Luba Trokan, Ouali Berkani |
|
| 2024-11-21 |
[Viewpoint] Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease |
Francesco Ciccia, Saviana Gandolfo, Roberto Caporali, Jose U Scher |
|
| 2024-11-20 |
[Articles] Association of historical redlining and present-day racialised economic segregation with health-care utilisation among individuals with rheumatic conditions in Massachusetts and surrounding areas of the USA: a retrospective cohort study |
Sherry Yang, Leah Santacroce, Jamie E Collins, Candace H Feldman |
|
| 2024-11-20 |
[Clinical Picture] Coronary polyarteritis nodosa |
Yi-Ning Yen, Hsien-Tzung Liao |
|
| 2024-11-20 |
[Comment] Structural racism is a driver of fragmented care and acute care use among people with rheumatic conditions |
João Luiz Bastos |
|
| 2024-11-16 |
[Comment] Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade |
Jill P Buyon, Philip M Carlucci, Bettina F Cuneo, Mala Masson, Peter Izmirly, Nalani Sachan, Justin S Brandt, Shilpi Mehta-Lee, Marc Halushka, Kristen Thomas, Melanie Fox, Colin KL Phoon, Achiau Ludomirsky, Ranjini Srinivasan, Garrett Lam, Benjamin J Wain |
|
| 2024-11-12 |
[Comment] Palliative care in patients with rheumatic diseases |
Bjoern Buehring, Sen Hee Tay, Erika Manu, Raymond Yung |
|
| 2024-11-12 |
[Comment] Ageism and rheumatic diseases |
Devyani Misra, Bjoern Buehring, Raymond Yung, Una E Makris |
|
| 2024-11-12 |
[Series] Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities |
Elena Myasoedova, Sebastian E Sattui, Jiha Lee, John T O'Brien, Una E Makris |
|
| 2024-11-12 |
[Series] Frailty and rheumatic diseases: evidence to date and lessons learned |
Sarah B Lieber, Katherine D Wysham, Sebastian E Sattui, Raymond Yung, Devyani Misra |
|
| 2024-11-12 |
[Articles] CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series |
Janina Auth, Fabian Müller, Simon Völkl, Nadine Bayerl, Jörg H W Distler, Carlo Tur, Maria G Raimondo, Sara Chenguiti Fakhouri, Armin Atzinger, Birte Coppers, Markus Eckstein, Anna-Maria Liphardt, Tobias Bäuerle, Koray Tascilar, Michael Aigner, Sascha Kre |
|
| 2024-11-12 |
[Comment] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis |
Jérôme Avouac |
|
| 2024-11-12 |
[Series] Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist |
Bjoern Buehring, Marloes van Onna, Elena Myasoedova, Jiha Lee, Una E Makris |
|
| 2024-11-12 |
[Insights] Una Makris: What matters to older patients, matters most to her |
Jules Morgan |
|
| 2024-11-09 |
[Articles] Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study |
Guozhang Lin, Yuchen Wei, Huwen Wang, Christopher Boyer, Katherine Min Jia, Chi Tim Hung, Xiaoting Jiang, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S C Hui, Ka Chun Chong, E |
|
| 2024-11-09 |
[Articles] Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study |
Arthiha Velauthapillai, Catharina C Moor, Jeska K de Vries-Bouwstra, Marlies S Wijsenbeek-Lourens, Cornelia H M van den Ende, Madelon C Vonk |
|
| 2024-11-09 |
[Comment] Are we ready for home spirometry for systemic sclerosis-associated ILD? |
Jessica Channick, Elizabeth R Volkmann |
|
| 2024-11-09 |
[Comment] Immunosuppression, nirmatrelvir–ritonavir, and post-COVID condition |
Jeffrey A Sparks, Zachary S Wallace |
|
| 2024-11-06 |
[Viewpoint] Barriers to CAR T-cell therapy in rheumatology |
Karolina Lungova, Michael Putman |
|
| 2024-11-02 |
[Comment] Digital remote monitoring in rheumatology: using health economics to support wider adoption |
Sean P Gavan |
|
| 2024-11-02 |
[Articles] Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness |
Kasper Hermans, Casper Webers, Annelies Boonen, Harald E Vonkeman, Astrid van Tubergen |
|
| 2024-10-31 |
[Articles] Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study |
Mikkel Østergaard, Mikael Boesen, Walter P Maksymowych, Robert G Lambert, Michael R Bubb, Olga Kubassova, Guillermo Valenzuela, Jyotsna Reddy, Stephen Colgan, Yuri Klyachkin, Cynthia Deignan, Zhenwei Zhou, Hamid Amouzadeh, Philip J Mease |
|
| 2024-10-30 |
[Clinical Picture] Facial ulcerations in anti-MDA5 dermatomyositis |
Rajat Ranka, Sukdev Manna, Venkatesh Srinivasa Pai |
|
| 2024-10-30 |
[Review] Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework |
Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, Emanuele Bozzalla-Cassione, Chiara Cardamone, Cosimo Cigolini, Francesco Ferro, Tomas Fonseca, George E Fragoulis, Ilaria Galetti, Maria Gerosa, José Hernández-Rodríguez, Marco Lanzillotta, Diana Marin |
|
| 2024-10-23 |
[Articles] Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial |
Hong Zhang, Qianqian Li, Cuiyun Li, Min Wu, Hong Chen, Yang Li, Feng You, Yanshi Zhao, Jing Jin, Xiaoguang Chen, Yanhua Ding |
|
| 2024-10-23 |
[Comment] Proximod as a potential therapy for rheumatoid arthritis |
Chao Liang |
|
| 2024-10-19 |
[Review] Advancing personalised precision treatment for Still's disease based on molecular characteristics and disease progression |
Yujie Shen, Jinchao Jia, Jialin Teng, Chengde Yang, Qiongyi Hu |
|
| 2024-10-16 |
[Articles] Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study |
Mark D Russell, Mark Gibson, Benjamin Zuckerman, Kanta Kumar, Shirish Dubey, Maryam A Adas, Edward Alveyn, Samir Patel, Zijing Yang, Katie Bechman, Elizabeth Price, Sarah Gallagher, Andrew P Cope, Sam Norton, James B Galloway |
|
| 2024-10-16 |
[Correction] Correction to Lancet Rheumatol 2024; published Online Sept 18, 2024. https://doi.org/10.1016/S2665-9913(24)00220-0 |
|
|
| 2024-10-12 |
[Articles] Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial |
Amanda Malone, Mark M Kowalski, James Helliwell, Sidsel Lynggaard Boll, Helene Rovsing, Kathrine Moriat, Alejandro Castillo Mondragón, Yanqi Li, Claire Prener Miller, Asger Reinstrup Bihlet, Christine Dobek, Vik Peck, Mike Wilmink, Lee S Simon, Philip G C |
|
| 2024-10-04 |
[Correspondence] Inclusion of pregnant populations in clinical trials in China: the ethical considerations |
Xiaoyan Chen, Huifeng Shi, Barbara Wilkinson, Yuanfang Zhu |
|
| 2024-10-02 |
[Correspondence] Inclusive study design to better serve the needs of children and young people with rheumatological conditions |
Ameenat Lola Solebo, Salomey Kellett, UNICORNS Group |
|
| 2024-09-28 |
[Corrections] Correction to Lancet Rheumatol 2024; 6: e507–17 |
|
|
| 2024-09-28 |
[Clinical Picture] Constitutional symptoms of severe childhood-onset polyarteritis nodosa |
Pavneet Kaur, Srinivasavaradan Govindarajan, Manisha Jana, Aditi Sinha, Narendra Kumar Bagri |
|
| 2024-09-26 |
[Viewpoint] The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica |
Elizabeth Nettleton, Kylie Carlson, Michael Putman |
|
| 2024-09-25 |
[Comment] Challenges and solutions for cellular therapy development in autoimmune diseases |
Elizabeth R Volkmann, John Varga, Bruce R Blazar, Steven Z Pavletic |
|
| 2024-09-19 |
[Comment] Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults |
Alexandra Legge |
|
| 2024-09-19 |
[Articles] The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study |
Sebastian E Sattui, Bohang Jiang, Xiaoqing Fu, Claire Cook, Shruthi Srivatsan, Zachary K Williams, Guy Katz, Yuqing Zhang, Zachary S Wallace |
|
| 2024-09-19 |
[Articles] Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study |
Alexandra Kachaner, Arthur Mageau, Tiphaine Goulenok, Chrystelle François, Nicole Delory, Marie-Paule Chauveheid, Cedric Laouenan, Serge Doan, Caroline Halimi, Isabelle Klein, Thomas Papo, Karim Sacré, French Susac Study Group |
|
| 2024-09-19 |
[Comment] Susac syndrome: challenges of interpreting treatment data in a rare disease |
Todd A Hardy |
|
| 2024-09-18 |
[Articles] Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial |
Quirine A Dumoulin, Doortje I Krijbolder, Karen Visser, Leroy R Lard, Annette H M van der Helm-van Mil |
|
| 2024-09-18 |
[Comment] Prevention of seronegative rheumatoid arthritis: an entity of its own |
Serena Bugatti, Georg Schett |
|
| 2024-09-11 |
[Correspondence] Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases |
Begonya Alcacer-Pitarch, Francesco Del Galdo, Helena Marzo-Ortega |
|
| 2024-09-03 |
[Articles] Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial |
Zhenyu Zhong, Dan Deng, Yu Gao, Qingqing Bu, Lingyu Dai, Xiaojie Feng, Chong Tang, Xiang Luo, Yao Wang, Chunjiang Zhou, Guannan Su, Peizeng Yang |
|
| 2024-09-03 |
[Comment] Uveitis relapse in Behçet's disease: a more nuanced approach is needed |
Jian-long Guan, Jun Zou |
|
| 2024-08-29 |
[Articles] The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study |
Gabrielle Virgili-Gervais, Bianca Matthews, Elsa-Lynn Nassar, Marie-Eve Carrier, Linda Kwakkenbos, John D Pauling, Susan J Bartlett, Amy Gietzen, Karen Gottesman, Geneviève Guillot, Marie Hudson, Laura K Hummers, Amanda Lawrie-Jones, Vanessa L Malcarne, M |
|
| 2024-08-29 |
[Comment] Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis |
Maurizio Cutolo, Vanessa Smith, Elvis Hysa |
|
| 2024-08-27 |
[Articles] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials |
Ioannis Parodis, Julius Lindblom, Roger A Levy, Margherita Zen, Nursen Cetrez, Alvaro Gomez, Shereen Oon, Christine Henning, Munther Khamashta, Holly A Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour |
|
| 2024-08-27 |
[Comment] Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab |
George Bertsias, Jinoos Yazdany |
|
| 2024-08-23 |
[Articles] Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study |
Andreas V Goules, Loukas Chatzis, Vasilis C Pezoulas, Markos Patsouras, Clio Mavragani, Luca Quartuccio, Chiara Baldini, Salvatore De Vita, Dimitrios I Fotiadis, Athanasios G Tzioufas |
|
| 2024-08-23 |
[Articles] Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort |
Karl Gisslander, Arthur White, Louis Aslett, Zdenka Hrušková, Peter Lamprecht, Jacek Musiał, Jamsheela Nazeer, James Ng, Declan O'Sullivan, Xavier Puéchal, Matthew Rutherford, Mårten Segelmark, Benjamin Terrier, Vladimir Tesař, Michelangelo Tesi, Augusto |
|
| 2024-08-23 |
[Articles] Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study |
Juliette Rocca, Maxime Beydon, Véronique Le Guern, Eric Hachulla, Marion Couderc, Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Olivier Vittecoq, Christian Lavigne, Jean Schmidt, Claire Larroche, Xavier Mariette, Raphaèle Se |
|
| 2024-08-23 |
[Comment] A future for prediction and treatment of Sjögren's disease-associated lymphomas |
Suzanne Arends, Arjan Vissink, Frans G M Kroese, Gwenny M Verstappen, Hendrika Bootsma |
|
| 2024-08-23 |
[Comment] Reclassifying ANCA-associated vasculitis: a focus on kidney disease |
Ilay Berke, Andreas Kronbichler |
|
| 2024-08-15 |
[Comment] Pregnancy outcome predictors in systemic lupus erythematosus: prospective for brighter perspectives |
Grégoire Martin de Frémont, Jane E Salmon, Nathalie Costedoat-Chalumeau |
|
| 2024-08-15 |
[Articles] Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis |
Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper, Marieke Sueters, Y K Onno Teng, Isabel J Walter, Judith Kooiman |
|
| 2024-08-06 |
[Articles] Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study |
Melanie Nana, Maria Gregori, Eleanor Chandler, Hazel Powell, Bethan Goulden, Timothy Watts, Mandish K Dhanjal, Catherine Nelson-Piercy |
|
| 2024-08-06 |
[Comment] Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism |
Steven L Clark |
|
| 2024-08-01 |
[Comment] Advancing predictive accuracy for shoulder replacement surgery |
Erica Kholinne, Jae-Man Kwak |
|
| 2024-08-01 |
[Articles] Risk of serious adverse events after primary shoulder replacement: development and external validation of a prediction model using linked national data from England and Denmark |
Epaminondas Markos Valsamis, Marie Louise Jensen, Gillian Coward, Adrian Sayers, Rafael Pinedo-Villanueva, Jeppe V Rasmussen, Gary S Collins, Jonathan L Rees |
|
| 2024-07-30 |
[Review] Calcium pyrophosphate deposition disease |
Tristan Pascart, Georgios Filippou, Frédéric Lioté, Silvia Sirotti, Charlotte Jauffret, Abhishek Abhishek |
|
| 2024-07-30 |
[Review] Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis |
Dylan McGagh, Kaiyang Song, Hang Yuan, Andrew P Creagh, Sally Fenton, Wan-Fai Ng, Jennifer C Goldsack, William G Dixon, Aiden Doherty, Laura C Coates |
|
| 2024-07-25 |
[Articles] Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study |
Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Jonathan S Nguyen Van-Tam, Abhishek Abhishek |
|
| 2024-07-25 |
[Comment] Pneumococcal vaccine in adults with immune-mediated inflammatory diseases |
Meliha C Kapetanovic |
|
| 2024-07-18 |
[Viewpoint] Arthritis complicating inflammatory bowel disease— the future is now |
Kaiyang Song, Jack Satsangi, Laura C Coates |
|
| 2024-07-17 |
[Comment] Towards improving the Global Burden of Disease estimates for low back pain |
Mark Hancock, Alice Kongsted |
|
| 2024-07-17 |
[Articles] Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework |
YiFan Wu, Sarah Wulf Hanson, Garland Culbreth, Caroline Purcell, Peter Brooks, Jacek Kopec, Lyn March, Anthony D Woolf, Maja Pasovic, Erin Hamilton, Damian Santomauro, Theo Vos |
|
| 2024-07-17 |
[Insights] Fighting to be heard—a painful journey of misdiagnoses |
Luc J Beck, Katherine I Wolf |
|
| 2024-07-10 |
[Comment] Gout prevalence is rising in low-income and middle-income countries: are we ready? |
Kanon Jatuworapruk |
|
| 2024-07-10 |
[Articles] Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 |
GBD 2021 Gout Collaborators |
|
| 2024-07-04 |
[Review] Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care |
Laura E Eades, Alberta Y Hoi, Ruaidhri Liddle, Jason Sines, Rangi Kandane-Rathnayake, Sachin Khetan, Johannes Nossent, Greta Lindenmayer, Eric F Morand, David F L Liew, Maureen Rischmueller, Stephen Brady, Alex Brown, Fabien B Vincent |
|
| 2024-07-04 |
[Clinical Picture] Painful scalp nodules in SAPHO syndrome |
Clément Triaille, Victor Kokta, Julie Powell, Jean Jacques De Bruycker |
|
| 2024-07-03 |
[Corrections] Correction to Lancet Rheumatol 2023; 5: e130–38 |
|
|
| 2024-06-28 |
[Articles] Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study |
Titilola Falasinnu, Di Lu, Matthew C Baker |
|
| 2024-06-28 |
[Comment] Trends in opioid use for autoimmune rheumatic diseases |
Erika P Navarro-Mendoza, Alí Duarte-García |
|
| 2024-06-27 |
[Comment] Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study |
Elsa-Lynn Nassar, Gabrielle Virgili-Gervais, Marie-Eve Carrier, Linda Kwakkenbos, Richard S Henry, Sophie Hu, Sabrina Provencher, Meira Golberg, Susan J Bartlett, Luc Mouthon, Scott B Patten, John Varga, Andrea Benedetti, Brett D Thombs, Scleroderma Patie |
|
| 2024-06-26 |
[Articles] Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial |
Claudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, Benjamin A Fisher, Antoni Chan, Raj Sengupta, Jonathan Packham, Karl Gaffney, Nicola Gullick, Jonathan A Cook, Tim H Corn, James Teh, Pedro M Machado, Peter C Taylor, Paul Bowness |
|
| 2024-06-26 |
[Comment] Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts |
Walter P Maksymowych |
|
| 2024-06-20 |
[Clinical Picture] Pachydermodactyly: mimic of arthritis in a young man |
Cassandra Michelle Skinner-Taylor, Pablo Gamez-Siller, Brenda Cantu-Garza, Hector Guerra, Héctor Teodoro Rios-Bazaldua, Dionicio Angel Galarza-Delgado, Jesus Alberto Cardenas-de la Garza |
|
| 2024-06-19 |
[Comment] Engagement of people with lived experience in studies published in high-impact rheumatology journals: a meta-research review |
Claire Adams, Elsa-Lynn Nassar, Julia Nordlund, Cassidy Dal Santo, Danielle B Rice, Vanessa Cook, Jill T Boruff, Brett D Thombs |
|
| 2024-06-18 |
[Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty |
Fu-Shan Xue, Dao-Yi Lin, Xiao-Chun Zheng |
|
| 2024-06-18 |
[Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty – Authors' reply |
Joakim Steiness, Troels Haxholdt Lunn, Daniel Hägi-Pedersen, Janus Christian Jakobsen, Ole Mathiesen |
|
| 2024-06-15 |
[Clinical Picture] Takayasu arteritis-associated periostitis in the distal femur mimicking periosteal osteosarcoma |
Mariko M Kawamura, Robert Nakayama, Sayaka I Yamaguchi, Satoshi Kamio, Toru Hirozane, Tomoaki Mori, Naofumi Asano, Hajime Okita, Morio Matsumoto, Masaya Nakamura |
|
| 2024-06-13 |
[Articles] Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries |
Eleana Bolla, Anne Grete Semb, Anne M Kerola, Eirik Ikdahl, Michelle Petri, Guillermo J Pons-Estel, George A Karpouzas, Petros P Sfikakis, Rosana Quintana, Durga Prasanna Misra, Eduardo Ferreira Borba, Ignacio Garcia-de la Torre, Tatiana V Popkova, Bahar |
|
| 2024-06-13 |
[Comment] Systemic lupus erythematosus: managing cardiovascular risk factors |
Anisur Rahman |
|
| 2024-06-12 |
[Articles] Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study |
Vera Golder, Rangi Kandane-Rathnayake, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Wu, Sandra V Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi H |
|
| 2024-06-12 |
[Comment] Research, pregnancy, and the ethics of parental consent |
Anne Drapkin Lyerly |
|
| 2024-06-12 |
[Insights] Silvia Aguilera: learning from lived experience |
Udani Samarasekera |
|
| 2024-06-12 |
[Series] The outcomes of children born to mothers with autoimmune rheumatic diseases |
Laura Andreoli, Jeanette Andersen, Tadej Avcin, Christina D Chambers, Elisa M Fazzi, Neil Marlow, Nico M Wulffraat, Angela Tincani |
|
| 2024-06-12 |
[Series] The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management |
Ian Giles, Iona Thorne, Nanna Surlemont Schmidt, Claire Reid, Amy Crossley, Monica Panca, Nick Freemantle, Clare Tower, Shouvik Dass, Shefali K Sharma, David Williams, Sean O'Neill, Radboud J E M Dolhain, Nataša Toplak, Kenneth Hodson, Catherine Nelson-Pi |
|
| 2024-06-12 |
[Series] Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people |
Karen Schreiber, Christine Graversgaard, Beverley J Hunt, James M S Wason, Nathalie Costedoat-Chalumeau, Silvia Aguilera, Marta M Guerra, Jane E Salmon |
|
| 2024-06-12 |
[Comment] For SLE activity and glucocorticoids: aim low |
Martin Aringer, Jinoos Yazdany |
|
| 2024-06-04 |
[Articles] Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study |
Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Sharon Douglas, Helen E Foster, Taunton R Southwood, Kimme L Hyrich, UK JIA Biologics Register |
|
| 2024-06-04 |
[Comment] Biosimilars in childhood chronic rheumatic diseases: friend or foe? |
Ilaria Maccora, Gabriele Simonini |
|
| 2024-05-31 |
[Articles] Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria |
Isha Jha, Grace A McMahon, Cory A Perugino, Guy Katz, Zachary S Wallace, Ana Fernandes, Bohang Jiang, Yuqing Zhang, Aubree E McMahon, Thomas V Guy, Hang Liu, Yasmin G Hernandez-Barco, Shiv Pillai, John H Stone |
|
| 2024-05-31 |
[Articles] Supporting self-management of low back pain with an internet intervention with and without telephone support in primary care (SupportBack 2): a randomised controlled trial of clinical and cost-effectiveness |
Adam W A Geraghty, Taeko Becque, Lisa C Roberts, Jonathan C Hill, Nadine E Foster, Lucy Yardley, Beth Stuart, David A Turner, Elaine Hay, Gareth Griffiths, Frances Webley, Lorraine Durcan, Alannah Morgan, Stephanie Hughes, Sarah Bathers, Stephanie Butler- |
|
